Product Information

LAMOTRIGINE ER 250 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.2532 per EA under NDC 31722024430. Its NADAC has been published 185 times since Feb 8, 2023.

FDA first approved this application on Dec 8, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LAMOTRIGINE ER 250 MG TABLET

lamotrigine extended-release
$1.2532per EA

Strength

250 mg/1

NDC

31722024430

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA213949

FDA Approved

12/8/2021

TE Code

AB

On Market Since

12/9/2021

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMOTRIGINE ER 250 MG TABLET has been published 185 times since Feb 8, 2023, and over the history we have for it it has declined 70.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2532 per EA
All-time high$4.2366 (Feb 15, 2023)
All-time low$1.1070 (Nov 19, 2025)
52-week high$1.3127
52-week low$1.1070
Median price$1.7648
Average price$1.9648
Largest weekly change+56.5% (Aug 21, 2024)
Weeks tracked185
Tracking sinceFeb 8, 2023

Price History

1W

-1.9%

1M

-1.9%

3M

+0.4%

6M

-4.5%

1Y

+1.2%

3Y

-51.4%

5Y

N/A

All

-70.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lamotrigine extended-release market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LAMOTRIGINE ER 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 250 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.2532 per EA (NDC 31722024430), effective Aug 19, 2026.

How has the price of LAMOTRIGINE ER 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMOTRIGINE ER 250 MG TABLET has declined 70.4%. It has been tracked across 185 weekly CMS publications since Feb 8, 2023.

What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 250 MG TABLET?

Since Feb 8, 2023, the NADAC for LAMOTRIGINE ER 250 MG TABLET has ranged from a low of $1.1070 (Nov 19, 2025) to a high of $4.2366 (Feb 15, 2023), with a median of $1.7648 per EA.

Are there cheaper alternatives to LAMOTRIGINE ER 250 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of LAMOTRIGINE ER 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LAMOTRIGINE ER 250 MG TABLET?

LAMOTRIGINE ER 250 MG TABLET (NDC 31722024430) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.